Avinger Inc (AVGR)
1.70
-0.04
(-2.58%)
USD |
NASDAQ |
Jul 08, 16:00
1.70
0.00 (0.00%)
After-Hours: 18:21
Avinger SG&A Expense (Annual): 14.10M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 14.10M |
December 31, 2022 | 14.22M |
December 31, 2021 | 15.62M |
December 31, 2020 | 14.33M |
December 31, 2019 | 16.53M |
December 31, 2018 | 18.40M |
Date | Value |
---|---|
December 31, 2017 | 25.12M |
December 31, 2016 | 39.95M |
December 31, 2015 | 29.23M |
December 31, 2014 | 18.50M |
December 31, 2013 | 25.76M |
December 31, 2012 | 22.85M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
14.10M
Minimum
2023
16.53M
Maximum
2019
14.96M
Average
14.33M
Median
2020
SG&A Expense (Annual) Benchmarks
Perspective Therapeutics Inc | 21.06M |
Retractable Technologies Inc | 20.01M |
Xtant Medical Holdings Inc | 64.29M |
Asensus Surgical Inc | 36.08M |
Catheter Precision Inc | 17.12M |